Wed, May 1, 2024
Tue, April 30, 2024
Mon, April 29, 2024

Sumant Kulkarni Maintained (ANVS) at Strong Buy with Decreased Target to $26 on, Apr 30th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-26-on-apr-30th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Sumant Kulkarni of Canaccord Genuity, Maintained "Annovis Bio, Inc." (ANVS) at Strong Buy with Decreased Target from $36 to $26 on, Apr 30th, 2024.

Sumant has made no other calls on ANVS in the last 4 months.



There is 1 other peer that has a rating on ANVS. Out of the 1 peers that are also analyzing ANVS, all agrees with Sumant's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tyler Bussian of "Brookline Capital" Downgraded from Strong Buy to Hold and Held Target at $9 on, Wednesday, February 28th, 2024

Publication Contributing Sources